Publications by authors named "F Pinero"

Background And Aims: Despite liver transplantation (LT) is considered the optimal treatment for hepatocellular carcinoma (HCC), particularly in patients with impaired liver function, the shortage of donors has forced the application of very restrictive criteria for selecting ideal candidates for whom LT can offer the best outcome. With the evolving LT landscape due to the advent of direct-acting antivirals (DAAs) and the steady increase in donors, major efforts have been made to expand the transplant eligibility criteria for HCC. In addition, the emergence of immune checkpoint inhibitors (ICIs) for the treatment of HCC, with demonstrated efficacy in earlier stages, has revolutionized the therapeutic approach for these patients, and their integration in the setting of LT is challenging.

View Article and Find Full Text PDF
Article Synopsis
  • The study evaluates how the presence of concurrent LR-5 observations impacts the likelihood that LR-3 or LR-4 observations indicate hepatocellular carcinoma (HCC), using a meta-analysis approach.
  • The research analyzed data from 29 studies involving 2,591 observations across 1,456 patients, examining the predictive values of LR-3 and LR-4 with and without concurrent LR-5 observations.
  • Results showed no significant difference in the positive predictive value for LR-3 and LR-4 observations whether concurrent LR-5 was present or not, suggesting that the presence of LR-5 does not substantially affect HCC diagnosis.
View Article and Find Full Text PDF

Explant-based models for assessing HCC recurrence after liver transplantation serve as the gold standard, guiding post-liver transplantation screening and immunosuppression adjustment. Incorporating alpha-fetoprotein (AFP) levels into these models, such as the novel R3-AFP score, has notably enhanced risk stratification. However, validation of these models in high-evidence data is mandatory.

View Article and Find Full Text PDF

The optimal cutoff value of calcitonin (Ctn) levels measured using an electrochemiluminescence immunoassay (ECLIA) obtained from the washout fluid of fine needle aspiration (FNA-Ctn) for the diagnosis of medullary thyroid carcinoma (MTC) is currently not established. We evaluated the diagnostic accuracy and clinical utility of FNA-Ctn for the diagnosis and location of MTC in patients with nodular or multinodular goiters. This was a case-control study nested on a prospective multicenter cohort of patients with nodular or multinodular goiter, normal or elevated serum Ctn, and thyroidectomy indications.

View Article and Find Full Text PDF